Tumor necrosis factor α-producing cells in the intestinal mucosa of children with inflammatory bowel disease

Gastroenterology

Volumn 106, Issue 6, 1994, Pages 1455-1466

  Breese, Emma J ^a   Michie, Colin A ^b   Nicholls, Stuart W ^a   Murch, Simon H ^a   Williams, Christopher B ^a   Domizio, Paola ^a   Walker Smith, John A ^a   Macdonald, Thomas T ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYCLOSPORIN; CYCLOSPORIN A; MESALAZINE; PREDNISOLONE; STEROID; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; CROHN DISEASE; ENTERIC FEEDING; ENTERITIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INTESTINE MUCOSA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; ULCERATIVE COLITIS;

EID: 0028236232     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(94)90398-0     Document Type: Article

References (55)

1. Heterogeneity of HLA-DR positive histiocytes in human intestinal lamina propria: a combined histochemical and immunohistological analysis
2. Macrophage heterogeneity in normal colonic mucosa and inflammatory bowel disease
3. Immunohistochemical characterisation of macrophages in human liver and gastrointestinal tract: expression of CD4, HLA-DR, OKM1, and the mature macrophage marker 25F9 in normal and diseased tissue
4. Dendritic cells and scavenger macrophages in chronic inflammatory bowel disease
5. Interleukin 2 receptor expression by macrophages in inflammatory bowel disease
6. Respiratory burst activity of intestinal macrophages in normal and inflammatory bowel disease
7. Changes in phenotypically distinct mucosal macrophage population may be a prerequisite for development of inflammatory bowel disease
8. Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis
9. Recombinant interleukin 1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis
10. Inflammatory properties of recombinant tumour necrosis in rabbit skin in vivo
11. The inducing role of tumour necrosis factor in the development of bactericidal granulomas during BCG infection
12. Tumour necrosis factor α restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice
13. Modulation of endothelial cell hemostatic properties by TNF: insights into the role of endothelium in the host response to inflammatory stimuli
14. Bowel necrosis induced by tumour necrosis factor in rats is mediated by platelet-activating factor
15. Effect of tumour necrosis factor on epithelial tight junctions and transepithelial permeability
16. The effect of recombinant tumour necrosis factor on growth and macromolecular synthesis of human epithelial cells
17. Synergistic antitumour effects of tumour necrosis factor and interferon on human colon carcinoma cell lines
18. Triggered human mucosal T cells release tumour necrosis factor-alpha and interferon-gamma which kill human colonic epithelial cells
19. Serum concentrations of tumour necrosis factor α in childhood chronic inflammatory bowel disease
20. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation
21. Tumour necrosis factor-alpha and interferon-gamma production measured at a single cell level in normal and inflamed human intestine
22. Immunohistochemical localisation of tumour necrosis factor in chronic inflammatory bowel disease
23. Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation
24. Tumor necrosis factorex, interleukin-1β, and interleukin-6 expression in inflammatory bowel disease
25. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification
26. A clinical scoring system for chronic inflammatory bowel disease in children
27. Selective biopsy of human Peyer's patches during ileal endoscopy
28. Measurement of cytokine release by human cells: a quantitative analysis at the single cell level using the reverse haemolytic plaque assay
29. T-cell activation can induce either mucosal destruction or adaptation in cultured human fetal intestine
30. Detection of hormone release from individual cells in mixed populations using a reverse haemolytic plaque assay
31. A simple azo-dye method for histochemical demonstration of acid phophatase
32. Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor α
33. Prolongation of survival of human polymorphonuclear leukocytes by granulocytemacrophage colony stimulating factor is caused by inhibition of programmed cell death
34. Tumor necrosis factor is a critical mediator in the hapten induced irritant and contact sensitivity reactions
35. Requirement for tumor necrosis factor for development of silica-induced pulmonary fibrosis
36. Tumor necrosis factor alpha/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis
37. Tumor necrosis factor / cachectin is an effector of skin and gut lesions of the acute phase of graft-versus-host disease
38. Spontaneous release of interferon by intestinal lamina propria lymphocytes in Crohn's disease
39. Interleukin-2 and interferon secreting T cells in normal and diseased human intestinal mucosa
40. Increased interleukin-2 mRNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis
41. Epithelial deposition of immunoglobulin G1 and activated complement (C3b and terminal complement complex) in ulcerative colitis
42. Evidence for local immune complexes in ulcerative colitis
43. The B cell system
44. Regulation of activated macrophage anti-microbial activities. Identification of lymphokines that cooperate with IFN-γ for induction of resistance to infection
45. Characterisation of IL-2 receptor expression and function on murine macrophages
46. National cooperative Crohn's disease study; results of drug treatment
47. A placebo-controlled, double-blind, randomised trial of cyclosporine therapy in active Crohn's disease
48. The effect of elemental diet on intestinal permeability and inflammation in Crohn's disease
49. Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone
50. Glucocorticoid treatment in ileal Crohn's disease: relief of symptoms but not of endoscopically viewed inflammation
51. Controlled trial comparing two types of enterai nutrition in treatment of active Crohn's disease: elemental vs polymeric diet
52. Effect of cyclosporin A and dexamethasone on interleukin 2 receptor gene expression
53. Tumour-necrosis-factor antibody treatment in crohn's disease